423 related articles for article (PubMed ID: 31740269)
21. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.
Milde S; Fox AN; Freeman MR; Coleman MP
Sci Rep; 2013; 3():2567. PubMed ID: 23995269
[TBL] [Abstract][Full Text] [Related]
22. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.
Milde S; Gilley J; Coleman MP
Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial Localization of SARM1 in Acrylamide Intoxication Induces Mitophagy and Limits Neuropathy.
Wang S; Song M; Yong H; Zhang C; Kang K; Liu Z; Yang Y; Huang Z; Wang S; Ge H; Zhao X; Song F
Mol Neurobiol; 2022 Dec; 59(12):7337-7353. PubMed ID: 36171479
[TBL] [Abstract][Full Text] [Related]
24. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
Yamagishi Y; Tessier-Lavigne M
Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
[TBL] [Abstract][Full Text] [Related]
25. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
Yang S; Niou ZX; Enriquez A; LaMar J; Huang JY; Ling K; Jafar-Nejad P; Gilley J; Coleman MP; Tennessen JM; Rangaraju V; Lu HC
Mol Neurodegener; 2024 Jan; 19(1):13. PubMed ID: 38282024
[TBL] [Abstract][Full Text] [Related]
26. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
27. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
[TBL] [Abstract][Full Text] [Related]
28. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
Ko KW; Milbrandt J; DiAntonio A
J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
[TBL] [Abstract][Full Text] [Related]
29. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
Summers DW; Milbrandt J; DiAntonio A
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
[TBL] [Abstract][Full Text] [Related]
30. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection.
Sasaki Y; Zhu J; Shi Y; Gu W; Kobe B; Ve T; DiAntonio A; Milbrandt J
Exp Neurol; 2021 Nov; 345():113842. PubMed ID: 34403688
[TBL] [Abstract][Full Text] [Related]
31. Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods.
Ziogas NK; Koliatsos VE
J Neurosci; 2018 Apr; 38(16):4031-4047. PubMed ID: 29567804
[TBL] [Abstract][Full Text] [Related]
32. NAD
Alexandris AS; Koliatsos VE
Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
[No Abstract] [Full Text] [Related]
33. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
34. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
[TBL] [Abstract][Full Text] [Related]
35. Excitotoxicity upregulates SARM1 protein expression and promotes Wallerian-like degeneration of retinal ganglion cells and their axons.
Massoll C; Mando W; Chintala SK
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2771-80. PubMed ID: 23518770
[TBL] [Abstract][Full Text] [Related]
36. Macrophage depletion blocks congenital SARM1-dependent neuropathy.
Dingwall CB; Strickland A; Yum SW; Yim AK; Zhu J; Wang PL; Yamada Y; Schmidt RE; Sasaki Y; Bloom AJ; DiAntonio A; Milbrandt J
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36287209
[TBL] [Abstract][Full Text] [Related]
37. NMNAT2: An important metabolic enzyme affecting the disease progression.
Li W; Gao M; Hu C; Chen X; Zhou Y
Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916
[TBL] [Abstract][Full Text] [Related]
38. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.
Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW
Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762
[TBL] [Abstract][Full Text] [Related]
39. Activation of the CaMKII-Sarm1-ASK1-p38 MAP kinase pathway protects against axon degeneration caused by loss of mitochondria.
Ding C; Wu Y; Dabas H; Hammarlund M
Elife; 2022 Mar; 11():. PubMed ID: 35285800
[TBL] [Abstract][Full Text] [Related]
40. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.
Avery MA; Rooney TM; Pandya JD; Wishart TM; Gillingwater TH; Geddes JW; Sullivan PG; Freeman MR
Curr Biol; 2012 Apr; 22(7):596-600. PubMed ID: 22425157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
